Sugi : Notification on Revision of Consolidated Earnings Forecast
December 28, 2021 at 01:47 am EST
Share
December 28, 2021
To Whom It May Concern:
Company: SUGI Holdings Co., Ltd.
Representative: Katsunori Sugiura, Representative Director and President
(Code number: 7649, First Section of TSE / Nagoya Stock Exchange) Inquiries: Makoto Kasai, General Manager, Business Planning Department (Phone: +81-562-45-2744)
Notification on Revision of Consolidated Earnings Forecast
In light of recent trends in our business performance, we have revised the full-year of the fiscal year ending February 28,2022, announced on June 29,2021.
Revision of Consolidated Earnings Forecast for the Fiscal Year Ending February 28, 2022 (March 1, 2021 to February 28, 2022)
Profit
Net sales
Operating
Ordinary
attributable to
Earnings Per
income
income
owners of
Share
parent
Previous forecast (A)
million yen
million yen
million yen
million yen
Yen
650,300
34,300
35,500
22,000
355.91
Revised forecast (B)
625,000
31,000
32,000
18,300
296.05
Changed Amount (B-A)
△25,300
△3,300
△3,500
△3,700
Changed Ratio (%)
△3.9
△9.6
△9.9
△16.8
(Reference)
Yen
Previous results
602,850
34,041
35,333
21,120
341.68
(FY ended February 28, 2021)
Note: Due to change in the method of presentation in the first quarter of the fiscal year ending February 28, 2022, the figures for net sales and operating income in the consolidated financial results for the fiscal year ended February 28, 2021 have been reclassified to reflect the change.
● Reasons for the revision
In this fiscal year, the Company has been working on various measures to strengthen our sales force, such as reinforcing stores with dispensing and expanding the food sales floor to meet the changing needs of the market. However, net sales and profits fell short of the initially announced forecast due to decline in demand for products to combat the new coronavirus and nesting demand, which had grown significantly in the previous fiscal year, as well as a prolonged decline in demand for cosmetics and OTC drugs due to the regular use of masks and increased hygiene awareness.
As for the future, there are many uncertainties such as occurrence of new variant, and recovery is expected to be difficult for in the full fiscal year, for these reason the Company had made a downward revision for earnings forecast.
*The above earnings forecasts are based on current available information. Actual results may differ from forecasted figures above due to various factors.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Sugi Holdings Co. Ltd. published this content on 28 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 December 2021 06:46:09 UTC.
SUGI HOLDINGS CO.,LTD. is a Japan-based holding company mainly engaged in management of the drug stores and dispensing business. Through its subsidiaries, the Company is engaged in the sale of medicines, health foods, cosmetics, daily necessities and prescription preparations, as well as the operation of local healthcare compliant drug store that tackles home healthcare in cooperation with regional medical personnel. The Company also operates visiting nursing stations that closely cooperate with regional medical institutions and social welfare operators, through the provision of visiting nursing services and in-home nursing care support services.